Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors
Doxorubicin (Dox) treatment is limited by severe toxicity and frequent episodes of treatment failure. To minimize adverse events and improve drug delivery efficiently and specifically in cancer cells, encapsulation of Dox with naturally obtained galactoxyloglucan polysaccharide (PST001), isolated fr...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2014-10-01
|
| Col·lecció: | Translational Oncology |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S193652331400076X |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|